Condition: Transcatheter Aortic Valve Replacemen · Echocardiography · Sponsor: Pan Xiangbin
Conventional transcatheter aortic valve replacement (TAVR) relies on fluoroscopic and contrast agents. However, in high-risk patients, exposure to ionizing radiation and contrast agents is contraindicated and undesirable. Echocardiography guidance TAVR can offer a feasible and safer strategy for TAVR.
This description comes directly from the study's public registry record.
Xiangbin Pan, MD · 88396655 · panxiangbin@fuwaihospital.org
Fengwen Zhang, MD · 88396654
Always discuss trial participation with your own doctor first.
| Fuwai Hospital | Beijing, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07030062